Government Settles with Stryker Biotech for $15 Million, Drops Charges Against Execs

The government’s case against Stryker Biotech and three of its executives was set to be a rare instance of an off-label marketing case going before a jury. But after only two days of trial, prosecutors reached a $15 million settlement with the company and dropped charges against the executives.

View full post on Law.com – Newswire

, , , , , , , ,

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Get Adobe Flash player
SEO Powered by Platinum SEO from Techblissonline
© 1992-2012 DC2NET™, Inc. All Rights Reserved